Common Contracts
1 similar Regn-Cov2 Supply Agreement for Pandemic Purposes contracts
REGN-COV2 SUPPLY AGREEMENT FOR PANDEMIC PURPOSESRegn-Cov2 Supply Agreement for Pandemic Purposes • April 5th, 2021
UK has informed Roche that it is taking preparatory measures to counter the COVID-19 pandemic. UK wishes to purchase a quantity of Units (as defined in Annex A) of the pharmaceutical product known as REGN-COV2 (being a casirivimab and imdevimab combo pack) (“Product”) as part of its preparatory measures. As such, UK has agreed to purchase a number of Units of the Product from Roche, and Roche has agreed to deliver that quantity of Units of Product to hospitals in the Territory on behalf of UK, and to use Commercially Reasonable Efforts (defined below) to secure an appropriate Marketing Approval (defined below) and other necessary regulatory approvals in the United Kingdom of Great Britain and Northern Ireland (the "Territory") for the sale and supply of the Product to the UK. To the extent a Marketing Approval is initially secured through Regulation 174 of the Human Medicines Regulations 2012, it is acknowledged than any such authorisation will require the applicable Secretary of State
